Literature DB >> 9254052

Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells.

S Chatterjee1, A K Bhunia, A Snowden, H Han.   

Abstract

Previously, our laboratory has shown that oxidized low density lipoproteins (Ox-LDL) can exert a concentration-dependent stimulation in the proliferation of aortic smooth muscle cells, "a hallmark in the pathogenesis of atherosclerosis" (Chatterjee, S. (1992) Mol. Cell. Biochem., 111, 143-147). Here we report a novel aspect of Ox-LDL-mediated signal transduction. We demonstrate that in aortic smooth muscle cells, Ox-LDL stimulates the activity of a UDP-galactose:glucosylceramide beta1-->4 galactosyltransferase (GalT-2) and phosphorylation/activation of p44 mitogen-activated protein (MAP) kinase (p44 MAPK). The activity of GalT-2 increased about 2-fold within 2.5-5 min of incubation of cells with Ox-LDL (10 microg/ml). After 5 min of incubation of cells with Ox-LDL, but not LDL, there was a 2-fold increase in the activity of p44 MAPK. Phosphoamino acid analysis employing thin layer chromatography revealed that the tyrosine and threonine moieties of p44 MAPK was phosphorylated by Ox-LDL. D-1-Phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP; a potent inhibitor of GalT-2) impaired the Ox-LDL mediated induction of p44 MAPK activity and the phosphorylation of tyrosine and threonine residues in p44 MAPK. This phenomenon was bypassed by the simultaneous addition of lactosylceramide. The upstream and downstream parameters in MAP kinase signaling pathways were investigated next. We found that Ox-LDL stimulated (9-fold) the loading of GTP on Ras. Interestingly, Ox-LDL specifically induced c-fos mRNA expression (6.5-fold) in these cells, as compared to the control. Thus, one of the biochemical mechanisms in Ox-LDL mediated induction in the proliferation in aortic smooth muscle cells may involve GalT-2 activation, lactosylceramide production, Ras GTP loading, activation of the kinase cascade, and c-fos expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9254052     DOI: 10.1093/glycob/7.5.703

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  14 in total

1.  Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells.

Authors:  Kasey C Vickers; Fernando Castro-Chavez; Joel D Morrisett
Journal:  Atherosclerosis       Date:  2010-04-14       Impact factor: 5.162

2.  Exposure to oxidized low-density lipoprotein reduces activable Ras protein in vascular endothelial cells.

Authors:  Shu-Er Chow; Wing-Keung Chu; Stephen H Shih; Jan-Kan Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-06       Impact factor: 2.416

3.  Hyperlipemia and oxidation of LDL induce vascular smooth muscle cell growth: an effect mediated by the HLH factor Id3.

Authors:  Angela M Taylor; Feng Li; Pushpa Thimmalapura; Ross G Gerrity; Ian J Sarembock; Scott Forrest; Sarah Rutherford; Coleen A McNamara
Journal:  J Vasc Res       Date:  2005-12-07       Impact factor: 1.934

4.  Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway.

Authors:  C M Yang; C S Chien; L D Hsiao; S L Pan; C C Wang; C T Chiu; C C Lin
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/- mice and rabbits fed a high-fat and -cholesterol diet.

Authors:  Subroto Chatterjee; Djahida Bedja; Sumita Mishra; Christine Amuzie; Alberto Avolio; David A Kass; Dan Berkowitz; Mark Renehan
Journal:  Circulation       Date:  2014-04-07       Impact factor: 29.690

6.  Use of a novel anti-proliferative compound coated on a biopolymer to mitigate platelet-derived growth factor-induced proliferation in human aortic smooth muscle cells: comparison with sirolimus.

Authors:  Yong-Dan Tang; Ambarish Pandey; Antonina Kolmakova; Xin-Tong Wang; Subbu S Venkatraman; Subroto Chatterjee; Freddy Y C Boey
Journal:  Glycoconj J       Date:  2008-10-14       Impact factor: 2.916

7.  VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo.

Authors:  Antonina Kolmakova; Mohanraj Rajesh; David Zang; Roberto Pili; Subroto Chatterjee
Journal:  Glycoconj J       Date:  2009-02-14       Impact factor: 2.916

Review 8.  Killing tumours by ceramide-induced apoptosis: a critique of available drugs.

Authors:  Norman S Radin
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

9.  Glucose-oxidized low-density lipoproteins enhance insulin-like growth factor I-stimulated smooth muscle cell proliferation by inhibiting integrin-associated protein cleavage.

Authors:  Lee B Allen; Byron E Capps; Emily C Miller; David R Clemmons; Laura A Maile
Journal:  Endocrinology       Date:  2008-10-30       Impact factor: 4.736

10.  Use of a glycolipid inhibitor to ameliorate renal cancer in a mouse model.

Authors:  Subroto Chatterjee; Nezar Alsaeedi; Jennifer Hou; Veera Venkata Ratnam Bandaru; Lan Wu; Marc K Halushka; Roberto Pili; Georges Ndikuyeze; Norman J Haughey
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.